Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Rheumatoid Arthritis
100%
Treatment Strategy
100%
Treatment Decisions
100%
Clinical Practice Guidelines
100%
Complex Treatment
100%
Biological Response Modifiers
83%
Disease Activity
50%
Patient Characteristics
33%
Cost-effectiveness
33%
Patient Outcomes
33%
Physical Functioning
33%
Disease-modifying Antirheumatic Drugs (DMARDs)
33%
Health Utility
33%
Drug Response
33%
Treatment History
33%
Drug Sequencing
33%
Disease Treatment
16%
Treatment Effect
16%
Dutch
16%
Linear Mixed Model
16%
Treatment Efficacy
16%
Monte Carlo Simulation
16%
Probability Distribution
16%
Western Countries
16%
Cost-utility
16%
Knowledge Gaps
16%
Real-life Data
16%
Modeling Approach
16%
Randomized Controlled Clinical Trial
16%
Patient Treatment
16%
Treatment Pathways
16%
Quality-adjusted Life Years
16%
Dutch Society
16%
Patient Costs
16%
Dutch Guideline
16%
Life-years Gained
16%
Outcome Efficacy
16%
Willingness-to-pay Threshold
16%
Incremental Cost
16%
Model-driven Development
16%
Probabilistic Sensitivity Analysis
16%
Long-term Development
16%
Long-stay Patients
16%
Rheumatology
16%
Time-to-event
16%
Discrete Event Simulation
16%
Activity History
16%
Two-part Model
16%
Dominated Strategies
16%
Sequence-independent
16%
Activity-based Costing
16%
INIS
patients
100%
arthritis
100%
modeling
100%
guidelines
100%
cost
75%
diseases
62%
drugs
50%
data
37%
comparative evaluations
37%
simulation
37%
management
37%
inclusions
25%
probability
25%
utilities
25%
demand
12%
clinical trials
12%
death
12%
distribution
12%
monte carlo method
12%
sensitivity analysis
12%
probabilistic estimation
12%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
100%
Outcome Modeling
100%
Biological Response Modifier
100%
Inflammatory Arthritis
100%
Disease Activity
60%
Disease Modifying Antirheumatic Drug
40%
Observational Study
20%
Combination Therapy
20%
Controlled Clinical Trial
20%